MORGAN STANLEY PLC/CALL/STRYKER CORP./420/0.1/20.12.24 Stock

Warrant

DE000MB85SR5

Market Closed - Börse Stuttgart 12:53:53 2024-06-07 pm EDT
0.41 EUR +7.89% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./420/0.1/20.12.24
Current month+24.24%
1 month+28.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 0.41 +7.89%
24-06-06 0.38 +2.70%
24-06-05 0.37 +2.78%
24-06-04 0.36 +5.88%
24-06-03 0.34 +3.03%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 12:53 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB85SR
ISINDE000MB85SR5
Date issued 2023-06-30
Strike 420 $
Maturity 2024-12-20 (196 Days)
Parity 10 : 1
Emission price 0.71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.24
Lowest since issue 0.21
Spread 0.04
Spread %9.09%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.3 USD
Average target price
373.1 USD
Spread / Average Target
+6.80%
Consensus